Pulmonary wedge resection plus parietal pleurectomy (WRPP) versus parietal pleurectomy (PP) for the treatment of recurrent primary pneumothorax (WOPP trial): study protocol for a randomized controlled trial

Jens Neudecker, Uwe Malzahn, Peter Heuschmann, Uwe Behrens, Thorsten Walles, Jens Neudecker, Uwe Malzahn, Peter Heuschmann, Uwe Behrens, Thorsten Walles

Abstract

Background: For the surgical treatment of recurrent primary spontaneous pneumothoraces (rPSP) different operative therapies are applied to achieve permanent freedom from recurrence.

Methods/design: This multicenter clinical trial evaluates the long-term results of two commonly applied surgical techniques for the treatment of rPSP. Based on the inclusion and exclusion criteria, and after obtaining the patients' informed consent, participants are randomized into the two surgical treatment arms: pulmonary wedge resection plus parietal pleurectomy (WRPP) or parietal pleurectomy alone (PP). Consecutively, all study participants will be followed up for two years to evaluate the surgical long-term effect. The primary efficacy endpoint is the recurrence rate of pneumothorax within 24 months after surgery. The calculated sample size is 360 patients (n = 180 per treatment arm) to prove superiority of one of the two treatments. So far, 22 surgical sites have submitted their declaration of commitment, giving the estimated number of participating patients.

Discussion: A prospective randomized clinical trial has been started to compare two established surgical therapies to evaluate the long-term results regarding recurrence rates. Furthermore, cost of treatment, and influence on the perioperative morbidity and mortality as well as on quality of life are analyzed. If the study reveals equivalence for both surgical techniques, unnecessary pulmonary resections could be avoided.

Trial registration: ClinicalTrials gov: NCT01855464 , 06.05 2013.

Figures

Fig. 1
Fig. 1
Course of the WOPP trial

References

    1. Henry M, Arnold T, Harvey J. BTS guidelines for the management of spontaneous pneumothorax. Thorax. 2003;58(Suppl II):ii39–52. doi: 10.1136/thx.58.suppl_2.ii39.
    1. Melton LJ, Hepper NCG, Offord KP. Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950–1974. Am Rev Respir Dis. 1979;29:1379–82.
    1. Bense L, Wiman LG, Hedenstierna G. Onset of symptoms in spontaneous pneumothorax: correlations to physical activity. Eur J Respir Dis. 1987;71:181–6.
    1. Chan JW, Ko FW, Ng CK, Yeung AW, Yee WK, So LK, et al. Management of patients admitted with pneumothorax: a multi-centre study of the practice and outcomes in Hong Kong. Hong Kong Med J. 2009;15(6):427–33.
    1. Gossot D, Galetta D, Stern JB, Debrosse D, Caliandro R, Girard P, et al. Results of thoracoscopic pleural abrasion for primary spontaneous pneumothorax. Surg Endosc. 2004;18:466–71. doi: 10.1007/s00464-003-9067-z.
    1. Sostheim UA. Operative management of spontaneous pneumothorax: long term results at the Schillerhöhe hospital. URL: (German)
    1. Czerny M, Salat A, Fleck T, Hofmann W, Zimpfer D, Eckersberger F, et al. Lung wedge resection improves outcome in stage I primary spontaneous pneumothorax. Ann Thorac Surg. 2004;77:1802–5. doi: 10.1016/j.athoracsur.2003.10.057.
    1. Ackermann C. 10-year experience in parietal pleurectomy for treatment of pneumothorax. Helv Chir Acta. 1985;52:213–7.
    1. Chambers A, Scarci M. In patients with first-episode primary spontaneous pneumothorax is video-assisted thoracoscopic surgery superior to tube thoracostomy alone in terms of time to resolution of pneumothorax and incidence of recurrence? Interact Cardiovasc Thorac Surg. 2009;9(6):1003–8. doi: 10.1510/icvts.2009.216473.
    1. Kelly AM, Kerr D, Clooney M. Outcomes of emergency department patients treated for primary spontaneous pneumothorax. Chest. 2008;134(5):1033–6. doi: 10.1378/chest.08-0910.
    1. Hürtgen M, Buhr J, Schwemmle K, Linder A, Friedel G. Video-assisted thoracoscopic surgery for spontaneous pneumothorax — results after 4 years. Min Invas Ther Allied Technol. 1996;5:528–33. doi: 10.3109/13645709609152696.
    1. Hürtgen M, Linder A, Friedel G, Toomes H. Videoassisted thoracoscopic pleurodesis. A survey conducted by the German Society for Thoracic Surgery. Thorac Cardiovasc Surg. 1996;44:199–203. doi: 10.1055/s-2007-1012016.
    1. Hürtgen M, Linder A, Friedel G, Toomes H. [Determination of established techniques for pleurodesis for pneumothorax treatment]. Zentralbl Chir 1997; 122(8);628–32 (German).
    1. Steger V, Walles T, Walker T, Friedel G. Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax. Eur Respir J. 2007;30:598–9. doi: 10.1183/09031936.00059307.
    1. [Primary and secondary pneumothorax] In: AWMF online. (German). Accessed 14 October 2015.
    1. Anheier H. Economic constraints in the hospital: Do not accept without resistance. Deutsch Ärztebl. 2010;107(14):A647 (German).
    1. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. In: World Medical Association. . Accessed 21 October 2015.
    1. Eudralex Volume 10 Guidelines on Good Clinical Practice (ICH E6: Good Clinical Practice: Consolidated guideline, CPMP/ICH/135/95. In: European Compliance Academy (ECA). . Accessed 21 October 2015.
    1. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. . Accessed 21 October 2015.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する